Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant AC with GM-CSF Followed by Carboplatin/Paclitaxel +/- Trastuzumab in Breast Cancer
NCT00256243Phase 2Completed
- Start
- Apr 2004
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim, carboplatin in breast cancer. Started Apr 2004; status: completed.
02
Drugs
sargramostimcarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00256243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256243.